This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Jan M Van Der Laan: Innovator in Penicillin G Acylase Research
Introduction
Jan M Van Der Laan is a notable inventor based in Breda AP, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the area of penicillin G acylases. His work focuses on the development of mutant enzymes that exhibit altered substrate specificities, which can have important implications in pharmaceutical applications.
Latest Patents
Jan M Van Der Laan holds a patent for "Mutated penicillin G acylase genes - New mutant." This patent describes the creation of new mutant β-lactam penicillin G acylases that are obtained by expressing a gene encoding said penicillin G acylase. These mutants differ from the wild-type penicillin G acylase by at least one amino acid in their sequence. This innovation opens up new possibilities for the use of penicillin G acylases in various biochemical processes.
Career Highlights
Throughout his career, Jan M Van Der Laan has focused on advancing the understanding of enzyme specificity and functionality. His research has contributed to the development of more efficient biocatalysts, which are essential in the production of antibiotics and other pharmaceuticals. His work is recognized for its potential to enhance the efficacy of drug development processes.
Collaborations
Jan M Van Der Laan has collaborated with esteemed colleagues in his field, including Adriana Marina Riemens and Wilhelmus J Quax. These collaborations have fostered a productive research environment, leading to innovative discoveries and advancements in enzyme technology.
Conclusion
Jan M Van Der Laan is a prominent figure in the field of biochemistry, particularly known for his work on penicillin G acylases. His innovative research and patent contributions continue to influence the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile